Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759767 (1990).<\/p>\n
CAS Article Google Scholar <\/p>\n
Lee-Six, H. et al. The landscape of somatic mutation in normal colorectal epithelial cells. Nature 574, 532537 (2019).<\/p>\n
ADS CAS Article Google Scholar <\/p>\n
Brunner, S. F. et al. Somatic mutations and clonal dynamics in healthy and cirrhotic human liver. Nature 574, 538542 (2019).<\/p>\n
ADS CAS Article Google Scholar <\/p>\n
Martincorena, I. et al. Somatic mutant clones colonize the human esophagus with age. Science 362, 911917 (2018).<\/p>\n
ADS CAS Article Google Scholar <\/p>\n
Martincorena, I. et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 8806 (2015).<\/p>\n
ADS CAS Article Google Scholar <\/p>\n
Yoshida, K. et al. Tobacco smoking and somatic mutations in human bronchial epithelium. Nature 578, 266272 (2020).<\/p>\n
ADS CAS Article Google Scholar <\/p>\n
Lee-Six, H. et al. Population dynamics of normal human blood inferred from somatic mutations. Nature 561, 473478 (2018).<\/p>\n
ADS CAS Article Google Scholar <\/p>\n
Li, R. et al. Macroscopic somatic clonal expansion in morphologically normal human urothelium. Science 370, 8289 (2020).<\/p>\n
ADS CAS Article Google Scholar <\/p>\n
Lawson, A. R. J. et al. Extensive heterogeneity in somatic mutation and selection in the human bladder. Science 370, 7582 (2020).<\/p>\n
ADS CAS Article Google Scholar <\/p>\n
van Oers, J. M. et al. Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder. Int. J Cancer 119, 12121215 (2006).<\/p>\n
Article Google Scholar <\/p>\n
Hartmann, A. et al. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. Cancer Res. 62, 809818 (2002).<\/p>\n
CAS PubMed Google Scholar <\/p>\n
Knowles, M. A. & Hurst, C. D. Molecular biology of bladder cancer: New insights into pathogenesis and clinical diversity. Nat. Rev. Cancer 15, 2541 (2015).<\/p>\n
CAS Article Google Scholar <\/p>\n
Majewski, T. et al. Whole-organ genomic characterization of mucosal field effects initiating bladder carcinogenesis. Cell Rep. 26, 22412256 (2019).<\/p>\n
CAS Article Google Scholar <\/p>\n
Borah, S. et al. Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer. Science 347, 100610 (2015).<\/p>\n
ADS CAS Article Google Scholar <\/p>\n
Hayashi, Y. et al. TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer. Mol. Oncol. 14, 23752383 (2020).<\/p>\n
CAS Article Google Scholar <\/p>\n
Hayashi, Y. et al. Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross-sectional data. Int. J. Urol. 28, 774776 (2021).<\/p>\n
CAS Article Google Scholar <\/p>\n
Amin, M. B. et al. AJCC Cancer Staging Manual, eighth ed. (2017).<\/p>\n
Moch, H., Humphrey, P. A., Ulbright, T. M.& Reuter, V. E. International Agency for Research on Cancer: WHO Classification of Tumours of Urinary System and Male Genital Organs, fourth ed. (2016).<\/p>\n
Hayashi, Y. et al. Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma. Cancer Sci. 110, 17711779 (2019).<\/p>\n
CAS Article Google Scholar <\/p>\n
Sakai, K. et al. Clonal composition of human ovarian cancer based on copy number analysis reveals a reciprocal relation with oncogenic mutation status. Cancer Lett. 405, 2228 (2017).<\/p>\n
ADS CAS Article Google Scholar <\/p>\n
Noguchi, T. et al. Comprehensive gene mutation profiling of circulating tumor DNA in ovarian cancer: Its pathological and prognostic impact. Cancers (Basel) 12, 3382 (2020).<\/p>\n
CAS Article Google Scholar <\/p>\n
Ploussard, G. et al. Prognostic value of loss of heterozygosity at chromosome 9p in non-muscle-invasive bladder cancer. Urology 76, 513 (2010).<\/p>\n
Article Google Scholar <\/p>\n
Krger, S., Mahnken, A., Kausch, I. & Feller, A. C. P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma. Eur. Urol. 47, 463467 (2005).<\/p>\n
Article Google Scholar <\/p>\n
Bartoletti, R. et al. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer. J. Surg. Res. 143, 422427 (2007).<\/p>\n
CAS Article Google Scholar <\/p>\n
Castillo-Martin, M., Domingo-Domenech, J., Karni-Schmidt, O., Matos, T. & Cordon-Cardo, C. Molecular pathways of urothelial development and bladder tumorigenesis. Urol. Oncol. 28, 401408 (2010).<\/p>\n
CAS Article Google Scholar <\/p>\n
Killela, P. J. et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc. Natl. Acad. Sci. U. S. A. 110, 60216 (2013).<\/p>\n
ADS CAS Article Google Scholar <\/p>\n
Huang, F. W. et al. Highly recurrent TERT promoter mutations in human melanoma. Science 339, 957959 (2013).<\/p>\n
ADS CAS Article Google Scholar <\/p>\n
Rodriguez, P. M. D. C. et al. Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder. Virchows Arch. 471, 761767 (2017).<\/p>\n
Article Google Scholar <\/p>\n
Nguyen, D. et al. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma. Virchows Arch. 469, 427434 (2016).<\/p>\n
CAS Article Google Scholar <\/p>\n
Cowan, M. L. et al. Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder. Hum. Pathol. 53, 813 (2016).<\/p>\n
CAS Article Google Scholar <\/p>\n
Cowan, M. et al. High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder. Mod. Pathol. 29, 511515 (2016).<\/p>\n
CAS Article Google Scholar <\/p>\n
Zheng, X. et al. High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins. J. Hematol. Oncol. 7, 47. https:\/\/doi.org\/10.1186\/s13045-014-0047-7<\/a> (2014).<\/p>\n CAS Article PubMed PubMed Central Google Scholar <\/p>\n Palsgrove, D. N. et al. Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations. Hum. Pathol. 85, 19 (2019).<\/p>\n CAS Article Google Scholar <\/p>\n Chiba, K. et al. Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism. Science 357, 14161420 (2017).<\/p>\n ADS CAS Article Google Scholar <\/p>\n Pietzak, E. J. et al. Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets. Eur. Urol. 72, 952959 (2017).<\/p>\n CAS Article Google Scholar <\/p>\n Robertson, A. G. et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 174, 1033 (2018).<\/p>\n CAS Article Google Scholar <\/p>\n Nabel, E. G. CDKs and CKIs: Molecular targets for tissue remodelling. Nat. Rev. Drug Discov. 1, 587598 (2002).<\/p>\n CAS Article Google Scholar <\/p>\n Witcher, M. & Emerson, B. M. Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. Mol. Cell. 34, 271284 (2009).<\/p>\n CAS Article Google Scholar <\/p>\n Petitjean, A., Achatz, M. I., Borresen-Dale, A. L., Hainaut, P. & Olivier, M. TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes. Oncogene 26, 21572165 (2007).<\/p>\n CAS Article Google Scholar <\/p>\n Springer, S. U. et al. Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy. Elife 7, e32143. https:\/\/doi.org\/10.7554\/eLife.32143<\/a> (2018).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n Hayashi, Y. et al. Clinical significance of hotspot mutation analysis of urinary cell-free DNA in urothelial bladder cancer. Front. Oncol. 10, 755. https:\/\/doi.org\/10.3389\/fonc.2020.00755<\/a> (2020).<\/p>\n Article PubMed PubMed Central Google Scholar <\/p>\n <\/p>\n View original post here: Fearon, E. Continue reading
\nTargeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer | Scientific Reports - Nature.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"